NCT02942225View on ClinicalTrials.gov

The Metabolome Profiling and Pathway Analysis of ADHD

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions
Attention-deficit/Hyperactivity Disorder
Trial Locations (1)

Unknown

National Taiwan Univeristy Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT02942225 - The Metabolome Profiling and Pathway Analysis of ADHD | Biotech Hunter | Biotech Hunter